Supplemental Figure 1. Characterization of peritoneal macrophages.
(A-B) GFP + cells infiltrated into peritoneal cavity were F4/80 + , CD11b + and CD68 + macrophages. Total peritoneal cells were harvested at various time points (2 h, 2-8 weeks) and were stained with anti-F4/80, CD11b and CD68 followed by FACS analyses. Representative images in (A) are shown for samples at 8 weeks. % of F4/80 + , CD11b + and CD68 + in the GFP + cell populations were quantified in (B), n=5. (C-D) CD11b + macrophages and CD11b + Gr1 + myeloid-derived suppressor cells in ascites at 1 and 6 weeks were analyzed by FACS (C). % of CD11b + and CD11b + Gr + cells were quantified (D), n=5, ***, P<0.001; (two-sided student's t-test). cisplatin, epirubicin and cyclophosphamide.
Supplemental Experimental Procedures
Counting tumor (mCherry) and macrophage (GFP + ) in ascites ID8 OC cells stably expressing mCherry fluorescence protein were implanted into 8-weeks old tomato lyz-cre recipient mice. Cherry + tumor cells and GFP + cells infiltrated into peritoneal cavity were detected at indicated times post-tumor cell implantation, and five mice were harvested at every time point. Collected ascites and counting total number by fluorescence microscope.
Monoclonal antibodies
Two blocking anti-mouse ICAM1 (cd54) and one blocking anti-human ICAM1 antibodies were used in these studies. Rat anti-mouse ICAM-1 monoclonal antibody YN1/1 was purified as previously described (1,2). Rat IgG was used as a control antibody (Santa cruz, Cat:sc-2026). Azide-free hamster anti-mouse ICAM1 monoclonal antibody 3E2 was purchased from BD Pharmingen (San Diego, CA). Anti-human ICAM1/CD54 antibody was purchased from R&D systems Inc (Minneapolis, MN; Cat: BBA3) Nonimmune hamster IgG was purchased from Pierce (Rockford, IL). These three antibody has also been shown to inhibit the function of murine ICAM1 (3-6).
3D co-culture system of TAM and ID8 cells
Mouse F4/80 + CD206 + TAMs were isolated by FACS sorting from spheroids of ovarian cancer-bearing donor tomato lyzM-cre mice. Human tumor spheroids from advanced stage (ie, Stage III-IV) ovarian cancer patients were harvested (IHC protocol # 1111003959) followed by FACS sorting for CD14+
TAMs. The 24-well plates were precoated with matrigel as described above. The mixtures of TAMs and ID8 cells (at ratio of 1:10 but with a fixed total cell number as 40,000 cells / well) were directly seeded onto the matrigel-precoated 24 well plate. The cells were incubated at 37℃ for up to 48
hours to allow the aggregates/spheroids to form. EGFR inhibitor Erlotinib, VEGFR3 inhibitor MAZ51
(20 nM each), CD11a (10μg/ml), CD11b (10μg/ml), CD11c (10μg/ml), Integrin β2 (10μg/ml) or anti-ICAM-1 antibody (20μg/ml) was added at 6 h after co-culture. Fluorescent microscopic images were taken to analyze the morphology from 6 -48 h. The wells without cells but containing medium were used as negative control. All assays were performed at least three times and each time was tested in triplicate. All microscopical images were observed using Zeiss Axiovert 200 fluorescence microscope (Carl Zeiss MicroImaging; Thornwood, NY), and images were captured using Openlab3 software (Improvision, Lexington, MA) (7, 8) .
In vivo treatment in mouse models
Mice were divided into groups of ten mice per group. An orthotopic mouse model was established by 
Immunohistochemical Staining
Paraffin-embedded spheroid samples isolated from the ascites of EOC patients (128 cases) were sectioned at a thickness of 4µm. To stain CD68, the slides were first deparaffinized in xylene and rehydrated with gradient concentrations of alcohol under standard procedures. After rehydration, the slides were immersed in 0.01 mol/L citrate buffer (pH 6.0) and heated (95°C) for 15 min for antigen retrieval. Then, the samples were incubated with 3% hydrogen peroxide (H 2 O 2 ) for 10 minutes followed by 10% normal goat serum blocking for 10 minutes. Subsequently, the sections were incubated with primary rabbit polyclonal anti-human CD68 antibody (dilution 1:100) (sc-20060, Santa
Cruz Biotechnology) for 1 hour at room temperature. After washing with PBST for 3 times, the sections were incubated with biotin-labeled secondary antibody followed by horseradish peroxidase (HRP)-conjugated streptavidin for 30 minutes individually at room temperature. After applying HRP substrate, 3.3'-diaminobenzidine tetrahydrochloride (D3939-1set, Sigma) in 0.01% H 2 O 2, for 10 minutes, the slides were counterstained with Meyer's hematoxylin for 30 to 60 seconds and mounted with mounting medium for visualization under microscope (9,10).
Semi-Quantitative Analysis of CD68 Staining
Scoring of CD68 in EOC samples via IHC staining follows the methods previously published. All of IHC staining samples from EOC patients were evaluated by experienced two pathologists independently.
Quantitative Analysis of EGF and VEGF-C Staining
Quantitative comparison of EGF and VEGF-C expression was determined using the freeware image analysis software, Image J, WS Rasband, National Health Institute, Bethesda, MA, USA) as previously reported (11) . Cell area was determined by manual delineation of raw fluorescence images. A minimum of 12 cells were analyzed from two independent experiments.
Follow-up evaluation
During the follow-up period, EOC patients with post-cytoreductive surgery and chemotherapy were requested to perform serum CA-125 test, pelvic MRI, color Doppler ultrasound of the liver and kidney, and pulmonary X-rays every three months in the first two years, every six months from 3 to 5 years, and annually thereafter. The end points of the study were progression-free (PFS) and overall survival (OS) as reported (12) . 
List of antibodies

